Resultado de búsqueda
Hace 22 horas · Key Takeaways. Standard BioTools reports a 2% increase in year-over-year revenue, with a significant contribution from SomaScan services. Non-GAAP operating expenses saw a 26% reduction, and adjusted EBITDA improved by 45%. The company is on track to achieve $50 million of the projected $80 million in operating synergies by the end of the year.
